- https://www.mybreo.com/
- https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Breo_Ellipta/pdf/BREO-ELLIPTA-PI-PIL-IFU.PDF
- https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Breo_Ellipta/pdf/BREO-ELLIPTA-PI-PIL-IFU.PDF#nameddest=PIL
- https://www.gsksource.com/pharma/content/gsk/source/us/en/brands/breo-asthma/pi/po.html
- http://www.fda.gov/medwatch
- http://www.gskforyou.com/
- https://www.gskforyou.com
- http://www.contactus.gsk.com/callback.html
- http://us.gsk.com/en-us/legal-notices/
- http://us.gsk.com/en-us/privacy/
- http://us.gsk.com/en-us/about-our-ads/
- https://www.contactus.gsk.com/optout/
- http://us.gsk.com/
quarta-feira, 7 de agosto de 2019
COPD & Asthma Medication | BREO ELLIPTA (fluticasone furoate and vilanterol)
Assinar:
Postar comentários (Atom)
Nenhum comentário:
Postar um comentário
Sua PRESENÇA Aqui!